Pilot production of recombinant human clotting factor IX from transgenic sow milk (Q45879062)

17 December 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Pilot production of recombinant human clotting factor IX from transgenic sow milk (English)

1 reference

17 December 2017

author name string

Yu-ling Sun

1

1 reference

17 December 2017

Yuo-sheng Chang

2

1 reference

17 December 2017

Yin-shen Lin

3

1 reference

17 December 2017

Chon-ho Yen

4

1 reference

17 December 2017

publication date

26 April 2012

1 reference

17 December 2017

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

published in

1 reference

17 December 2017

volume

898

1 reference

17 December 2017

page(s)

78-89

1 reference

17 December 2017

The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Activation of human factor IX (Christmas factor)

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

The molecular basis of blood coagulation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Identification of residues in the Gla-domain of human factor IX involved in the binding to conformation specific antibodies

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Recombinant human protein C expression in the milk of transgenic pigs and the effect on endogenous milk immunoglobulin and transferrin levels

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to overexpress VKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Activation of factor IX by factor XIa.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Expression of Human Anti-Hemophilic Factor IX in the Milk of Transgenic Sheep

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Model process for removal of caseins from milk of transgenic animals

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Recombinant factor IX (BeneFix) by adjusted continuous infusion: a study of stability, sterility and clinical experience

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Purification of recombinant DNA-derived factor IX produced in transgenic pig milk and fractionation of active and inactive subpopulations

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Purification and characterization of human factor IX

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Sustained release of transgenic human factor IX: preparation, characterization, and in vivo efficacy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

The carboxylation efficiency of the vitamin K-dependent clotting factors: studies with factor IX.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Vitamin K-Dependent Biosynthesis of γ-Carboxyglutamic Acid

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Inactivation and clearance of viruses during the manufacture of high purity factor IX.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Transgenic expression of a variant of human tissue-type plasminogen activator in goat milk: purification and characterization of the recombinant enzyme

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Effect of Ca2+ and Mg2+ concentration in culture medium on the activation of recombinant factor IX produced in Chinese hamster ovary cells.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Active gamma-carboxylated human factor IX expressed using recombinant DNA techniques

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Expression of active human factor IX in transfected cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Production of recombinant human von Willebrand factor in the milk of transgenic pigs

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Localization of the heparin binding exosite of factor IXa

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Transgenic pigs produce functional human factor VIII in milk

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.JCHROMB.2012.04.022

Identifiers

DOI

10.1016/J.JCHROMB.2012.04.022

1 reference

17 December 2017

1 reference

17 December 2017